Detalhe da pesquisa
1.
The association between telemedicine, advance care planning, and unplanned hospitalizations among high-risk patients with cancer.
Cancer
; 130(4): 636-644, 2024 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37987207
2.
Inverse Probability of Treatment Weighting and Confounder Missingness in Electronic Health Record-based Analyses: A Comparison of Approaches Using Plasmode Simulation.
Epidemiology
; 34(4): 520-530, 2023 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37155612
3.
Tumor Differentiation as a Prognostic Marker in Clinically Staged T1bN0 Esophageal Adenocarcinoma.
Cancer Invest
; 41(8): 734-738, 2023 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-37665657
4.
Association between timely targeted treatment and outcomes in patients with metastatic HER2-overexpressing gastroesophageal adenocarcinoma.
Cancer
; 128(9): 1853-1862, 2022 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35119688
5.
NCCN Guidelines® Insights: Bladder Cancer, Version 2.2022.
J Natl Compr Canc Netw
; 20(8): 866-878, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35948037
6.
Very high PD-L1 expression as a prognostic indicator of overall survival among patients with advanced non-small cell lung cancer receiving anti-PD-(L)1 monotherapies in routine practice.
Pharmacoepidemiol Drug Saf
; 31(10): 1121-1126, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35670103
7.
Integrating real world data and clinical trial results using survival data reconstruction and marginal moment-balancing weights.
J Biopharm Stat
; 32(1): 191-203, 2022 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34756156
8.
Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(7): 931-945, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051178
9.
Adherence to and determinants of guideline-recommended biomarker testing and targeted therapy in patients with gastroesophageal adenocarcinoma: Insights from routine practice.
Cancer
; 127(14): 2562-2570, 2021 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33730386
10.
Prognostic Implications of Tumor Differentiation in Clinical T1N0 Gastric Adenocarcinoma.
Oncologist
; 26(1): e111-e114, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32969129
11.
Identification of the Most Effective Position for Ustekinumab in Treatment Algorithms for Crohn's Disease.
Clin Gastroenterol Hepatol
; 19(10): 2082-2092.e10, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32801006
12.
Digoxin use is associated with pancreatic cancer risk but does not affect survival.
Cancer Causes Control
; 32(1): 41-46, 2021 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-33064241
13.
Inflammatory Bowel Diseases Are Associated With an Increased Risk for Chronic Kidney Disease, Which Decreases With Age.
Clin Gastroenterol Hepatol
; 18(10): 2262-2268, 2020 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31683056
14.
Geographical affiliation with top 10 NIH-funded academic medical centers and differences between mortality from cardiovascular disease and cancer.
Am Heart J
; 230: 54-58, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32950462
15.
First-line immune checkpoint inhibitor use in cisplatin-eligible patients with advanced urothelial carcinoma: a secular trend analysis.
Future Oncol
; 16(2): 4341-4345, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31840537
16.
Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study.
Pharmacoepidemiol Drug Saf
; 29(5): 599-604, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32196836
17.
Association between age and sex and mortality after adjuvant therapy for renal cancer.
Cancer
; 125(10): 1637-1644, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30620389
18.
Cisplatin versus cetuximab with definitive concurrent radiotherapy for head and neck squamous cell carcinoma: An analysis of Veterans Health Affairs data.
Cancer
; 125(3): 406-415, 2019 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30341983
19.
Trends in Checkpoint Inhibitor Therapy for Advanced Urothelial Cell Carcinoma at the End of Life: Insights from Real-World Practice.
Oncologist
; 24(6): e397-e399, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30944183
20.
Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer.
Oncologist
; 24(5): 688-690, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30728277